MEENAKSHI HEGDE

Concepts (177)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Immunotherapy, Adoptive
11
2025
823
2.420
Why?
Receptor, ErbB-2
9
2025
514
2.190
Why?
T-Lymphocytes
15
2025
1698
2.150
Why?
Glioblastoma
8
2018
334
1.560
Why?
Immunotherapy
7
2021
663
1.050
Why?
Interleukin-13 Receptor alpha2 Subunit
4
2018
20
0.900
Why?
Antigens, Neoplasm
4
2020
382
0.890
Why?
Brain Neoplasms
7
2020
1243
0.880
Why?
Sarcoma
2
2024
193
0.870
Why?
Receptors, Antigen, T-Cell
8
2020
481
0.860
Why?
Muscle Neoplasms
1
2020
21
0.690
Why?
Cancer Vaccines
3
2020
177
0.660
Why?
Tumor Escape
2
2016
61
0.620
Why?
Rhabdomyosarcoma
1
2020
200
0.570
Why?
Cell- and Tissue-Based Therapy
2
2017
159
0.540
Why?
Neoplasm Recurrence, Local
2
2020
1126
0.540
Why?
Adoptive Transfer
2
2014
237
0.490
Why?
Central Nervous System Neoplasms
1
2014
197
0.380
Why?
Hematopoietic Stem Cell Transplantation
4
2023
1194
0.360
Why?
Cell Line, Tumor
5
2025
3341
0.350
Why?
Hematologic Neoplasms
2
2025
283
0.350
Why?
Lymphocyte Activation
2
2025
688
0.310
Why?
Antibodies, Monoclonal
1
2014
1016
0.300
Why?
Lymphocyte Depletion
2
2024
124
0.280
Why?
Transplantation Conditioning
2
2018
323
0.250
Why?
Mice, SCID
3
2018
570
0.250
Why?
Xenograft Model Antitumor Assays
6
2020
887
0.240
Why?
Cyclophosphamide
2
2024
421
0.240
Why?
Immunological Synapses
1
2025
26
0.240
Why?
Membrane Microdomains
1
2025
59
0.230
Why?
Molecular Dynamics Simulation
1
2025
104
0.230
Why?
Vidarabine
1
2024
80
0.220
Why?
B7-H1 Antigen
1
2025
109
0.220
Why?
Neoplasms
3
2025
2761
0.220
Why?
Programmed Cell Death 1 Receptor
1
2025
120
0.220
Why?
Humans
29
2025
124307
0.220
Why?
Cord Blood Stem Cell Transplantation
1
2023
47
0.210
Why?
Mice
8
2025
17729
0.200
Why?
Antigens, CD19
2
2021
176
0.200
Why?
Leukocytes, Mononuclear
3
2022
327
0.200
Why?
Tumor Cells, Cultured
4
2020
1064
0.200
Why?
Treatment Outcome
6
2024
12292
0.180
Why?
Lymphoma
1
2024
321
0.180
Why?
Leukemia
1
2024
368
0.180
Why?
Clinical Trials, Phase I as Topic
1
2020
58
0.170
Why?
Leukemia, B-Cell
1
2020
26
0.170
Why?
Cerebrospinal Fluid
1
2020
95
0.170
Why?
Immunologic Memory
1
2021
185
0.170
Why?
Child
13
2025
24435
0.170
Why?
Transplantation, Autologous
1
2020
298
0.170
Why?
Remission Induction
1
2020
301
0.160
Why?
Animals
9
2025
34149
0.160
Why?
Transgenes
2
2020
337
0.160
Why?
Osteosarcoma
2
2019
258
0.160
Why?
Ependymoma
1
2020
134
0.160
Why?
Bone Marrow
1
2020
324
0.150
Why?
Epigenomics
1
2019
164
0.150
Why?
Receptor, EphA2
1
2018
26
0.150
Why?
Antigenic Variation
1
2018
39
0.150
Why?
Wiskott-Aldrich Syndrome
1
2017
22
0.150
Why?
Alemtuzumab
1
2018
88
0.150
Why?
Granulomatous Disease, Chronic
1
2018
65
0.140
Why?
Medulloblastoma
1
2020
340
0.130
Why?
Biopsy
1
2020
1237
0.130
Why?
Male
12
2025
60967
0.130
Why?
Prospective Studies
2
2024
6071
0.130
Why?
Head and Neck Neoplasms
1
2021
497
0.130
Why?
Protein Binding
2
2020
1750
0.130
Why?
Transplantation, Homologous
1
2018
661
0.130
Why?
Interleukin-13
1
2016
97
0.130
Why?
Protein Multimerization
1
2016
129
0.130
Why?
Carcinoma, Squamous Cell
1
2021
656
0.130
Why?
HEK293 Cells
2
2020
753
0.130
Why?
Neoplasm Transplantation
1
2016
374
0.120
Why?
Autoimmune Diseases
1
2018
251
0.120
Why?
Flow Cytometry
2
2015
802
0.120
Why?
Microspheres
1
2015
71
0.120
Why?
Receptors, Cell Surface
1
2017
469
0.120
Why?
Immediate-Early Proteins
1
2015
58
0.120
Why?
Viral Matrix Proteins
1
2015
109
0.120
Why?
Child, Preschool
8
2025
14042
0.120
Why?
Triple Negative Breast Neoplasms
1
2017
234
0.120
Why?
Immunophenotyping
1
2015
329
0.120
Why?
Follow-Up Studies
5
2025
5105
0.110
Why?
Adenocarcinoma
1
2021
998
0.110
Why?
Adult
7
2024
29385
0.110
Why?
Phosphoproteins
1
2015
404
0.110
Why?
Neoplasm Proteins
1
2017
669
0.110
Why?
Female
12
2025
66235
0.100
Why?
Cardiovascular Diseases
1
2025
1890
0.100
Why?
Aged
4
2024
19481
0.100
Why?
Cytotoxicity, Immunologic
2
2025
262
0.100
Why?
Genomics
1
2019
1489
0.090
Why?
Adolescent
8
2025
19300
0.090
Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
2018
779
0.090
Why?
Infant
6
2025
12473
0.090
Why?
Bone Neoplasms
1
2015
429
0.090
Why?
Recombinant Fusion Proteins
1
2013
767
0.090
Why?
Middle Aged
4
2024
26452
0.090
Why?
Antigens, Viral
1
2012
437
0.080
Why?
Combined Modality Therapy
1
2013
1244
0.080
Why?
Cytomegalovirus
3
2017
270
0.080
Why?
Models, Biological
1
2013
1459
0.070
Why?
Lung Neoplasms
1
2017
1598
0.070
Why?
Retrospective Studies
5
2025
16228
0.070
Why?
Antineoplastic Agents
1
2016
1658
0.070
Why?
Neoplasm Metastasis
2
2020
664
0.060
Why?
Tumor Necrosis Factor Receptor Superfamily, Member 9
1
2025
25
0.060
Why?
Pediatrics
1
2014
1154
0.060
Why?
CD28 Antigens
1
2025
78
0.060
Why?
Busulfan
1
2023
44
0.050
Why?
Survival Rate
2
2017
2020
0.050
Why?
Neutropenia
1
2024
200
0.050
Why?
Prognosis
2
2025
4549
0.050
Why?
Thrombocytopenia
1
2024
226
0.050
Why?
Apoptosis
2
2018
1787
0.050
Why?
Cell Proliferation
2
2018
2304
0.040
Why?
Injections, Intraventricular
1
2020
64
0.040
Why?
Immunity, Cellular
1
2021
202
0.040
Why?
T-Lymphocyte Subsets
1
2021
196
0.040
Why?
Treatment Failure
1
2021
342
0.040
Why?
Transduction, Genetic
1
2020
290
0.040
Why?
Drug Delivery Systems
1
2020
185
0.040
Why?
Gene Editing
1
2021
193
0.040
Why?
Structure-Activity Relationship
1
2020
572
0.040
Why?
CD8-Positive T-Lymphocytes
1
2021
393
0.040
Why?
Chimerism
1
2018
28
0.040
Why?
Guillain-Barre Syndrome
1
2018
28
0.040
Why?
Pancytopenia
1
2018
40
0.040
Why?
Unrelated Donors
1
2018
82
0.040
Why?
Mice, Inbred NOD
1
2018
285
0.040
Why?
Allografts
1
2017
192
0.030
Why?
Cerebellar Neoplasms
1
2020
285
0.030
Why?
History, 21st Century
1
2018
269
0.030
Why?
Mutation
2
2021
5806
0.030
Why?
Clinical Trials as Topic
1
2021
1084
0.030
Why?
Young Adult
2
2024
8974
0.030
Why?
Microfilament Proteins
1
2017
274
0.030
Why?
Proteomics
1
2019
491
0.030
Why?
Infant, Newborn
2
2019
8181
0.030
Why?
Polystyrenes
1
2015
13
0.030
Why?
Disease-Free Survival
1
2017
859
0.030
Why?
Color
1
2015
31
0.030
Why?
Neuroectodermal Tumors
1
2015
11
0.030
Why?
Gene Expression
1
2020
1570
0.030
Why?
Tumor Suppressor Protein p53
1
2019
719
0.030
Why?
Maximum Tolerated Dose
1
2015
158
0.030
Why?
Interleukin-13 Receptor alpha1 Subunit
1
2014
6
0.030
Why?
Immunotoxins
1
2014
21
0.030
Why?
Adenoviridae
1
2017
604
0.030
Why?
Mice, Transgenic
1
2020
2408
0.030
Why?
Cytokines
1
2020
1279
0.030
Why?
Herpesvirus 4, Human
1
2017
671
0.030
Why?
Leukocytes
1
2015
206
0.030
Why?
Fluorescent Dyes
1
2015
262
0.030
Why?
Sarcoma, Ewing
1
2015
117
0.030
Why?
Antibodies
1
2015
371
0.030
Why?
Positron-Emission Tomography
1
2015
298
0.030
Why?
Amino Acid Substitution
1
2014
393
0.030
Why?
Signal Transduction
1
2025
4536
0.030
Why?
Kaplan-Meier Estimate
1
2015
1017
0.020
Why?
Recurrence
1
2015
1422
0.020
Why?
Cell Separation
1
2012
229
0.020
Why?
In Situ Hybridization
1
2012
470
0.020
Why?
Biomarkers
1
2020
2971
0.020
Why?
Case-Control Studies
1
2017
3266
0.020
Why?
Recombinant Proteins
1
2014
1391
0.020
Why?
Incidence
1
2018
3080
0.020
Why?
Enzyme-Linked Immunosorbent Assay
1
2012
816
0.020
Why?
Biomarkers, Tumor
1
2017
1459
0.020
Why?
Cytomegalovirus Infections
1
2012
218
0.020
Why?
Disease Models, Animal
1
2020
4356
0.020
Why?
Tomography, X-Ray Computed
1
2015
2089
0.020
Why?
Gene Expression Regulation, Neoplastic
1
2014
1899
0.020
Why?
Cohort Studies
1
2015
4731
0.020
Why?
Magnetic Resonance Imaging
1
2015
3575
0.010
Why?
Risk Factors
1
2017
10141
0.010
Why?
HEGDE's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (177)
Explore
_
Co-Authors (66)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_